SCOPIA CAPITAL MANAGEMENT LP - Q2 2015 holdings

$5.15 Billion is the total value of SCOPIA CAPITAL MANAGEMENT LP's 39 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 43.3% .

 Value Shares↓ Weighting
SPR SellSPIRIT AEROSYSTEMS HLDGS INC$941,690,000
-18.2%
17,087,468
-22.5%
18.29%
-26.5%
IWM BuyISHARES TRput$384,069,000
+223.8%
3,140,900
+229.3%
7.46%
+190.8%
BIDU BuyBAIDU INCspon adr rep a$369,434,000
+22.8%
1,855,706
+28.6%
7.18%
+10.3%
UTHR SellUNITED THERAPEUTICS CORP DEL$367,193,000
-11.8%
2,110,909
-12.6%
7.13%
-20.8%
SPY BuySPDR S&P 500 ETF TRput$353,398,000
+189.4%
1,676,300
+183.4%
6.86%
+159.9%
FCEA BuyFOREST CITY ENTERPRISES INCcl a$340,586,000
+12.4%
15,411,110
+29.8%
6.62%
+1.0%
HUN BuyHUNTSMAN CORP$269,442,000
+93.5%
12,208,526
+94.4%
5.23%
+73.8%
ALR SellALERE INC$238,418,000
-5.8%
4,519,777
-12.7%
4.63%
-15.4%
MYGN BuyMYRIAD GENETICS INC$220,467,000
+7.2%
6,486,226
+11.6%
4.28%
-3.7%
VMW BuyVMWARE INC$153,543,000
+8.1%
1,790,800
+3.4%
2.98%
-2.9%
BKD SellBROOKDALE SR LIVING INC$145,788,000
-10.4%
4,201,375
-2.5%
2.83%
-19.6%
TFM BuyFRESH MKT INC$142,970,000
-9.9%
4,448,354
+13.9%
2.78%
-19.1%
SALE SellRETAILMENOT INC$119,427,000
-3.3%
6,698,114
-2.3%
2.32%
-13.1%
BCO BuyBRINKS CO$117,136,000
+16.2%
3,980,143
+9.1%
2.28%
+4.3%
AEGR BuyAEGERION PHARMACEUTICALS INC$102,980,000
-26.4%
5,428,586
+1.5%
2.00%
-33.9%
MLCO NewMELCO CROWN ENTMT LTDadr$101,613,0005,176,394
+100.0%
1.97%
MLNX SellMELLANOX TECHNOLOGIES LTD$91,343,000
-35.8%
1,879,871
-40.1%
1.77%
-42.3%
EXPR NewEXPRESS INC$76,381,0004,217,590
+100.0%
1.48%
XLE BuySELECT SECTOR SPDR TRsbi int-energy$75,319,000
-3.0%
1,002,109
+0.1%
1.46%
-12.9%
BNCL BuyBENEFICIAL BANCORP INC$75,064,000
+4259.1%
6,009,912
+3839.2%
1.46%
+3840.5%
MLCO NewMELCO CROWN ENTMT LTDcall$62,790,0003,000,000
+100.0%
1.22%
ARPI NewAMERICAN RESIDENTIAL PPTYS I$58,289,0003,150,753
+100.0%
1.13%
INFA SellINFORMATICA CORP$55,703,000
-78.2%
1,149,223
-80.3%
1.08%
-80.4%
AMH NewAMERICAN HOMES 4 RENTcl a$54,604,0003,404,215
+100.0%
1.06%
ZSPH SellZS PHARMA INC$48,450,000
+18.2%
924,804
-5.1%
0.94%
+6.1%
BA BuyBOEING COput$43,175,000
-4.6%
301,900
+0.1%
0.84%
-14.3%
INSYQ NewINSYS THERAPEUTICS INC NEW$31,319,000871,914
+100.0%
0.61%
DAR SellDARLING INGREDIENTS INC$24,174,000
-61.6%
1,648,980
-63.3%
0.47%
-65.5%
POST NewPOST HLDGS INC$17,527,000325,000
+100.0%
0.34%
AROPQ  AEROPOSTALE$16,041,000
-53.3%
9,901,9680.0%0.31%
-58.0%
RLYP BuyRELYPSA INC$12,395,000
+0.8%
374,588
+9.9%
0.24%
-9.4%
QLTI BuyQLT INC$12,006,000
+41.4%
2,907,096
+33.8%
0.23%
+26.6%
LNTH NewLANTHEUS HLDGS INC$10,900,0001,760,826
+100.0%
0.21%
FOSL NewFOSSIL GROUP INC$6,963,000100,390
+100.0%
0.14%
GNRC NewGENERAC HLDGS INC$3,097,00077,900
+100.0%
0.06%
ASND BuyASCENDIS PHARMA A Ssponsored adr$2,604,000
+20.1%
148,114
+18.5%
0.05%
+8.5%
KORS NewMICHAEL KORS HLDGS LTD$1,746,00041,481
+100.0%
0.03%
PSEC  PROSPECT CAPITAL CORPORATION$737,000
-12.8%
100,0000.0%0.01%
-22.2%
AMSC  AMERICAN SUPERCONDUCTOR CORP$103,000
-18.3%
19,6100.0%0.00%
-33.3%
PTLA ExitPORTOLA PHARMACEUTICALS INC$0-980,700
-100.0%
-0.80%
INTC ExitINTEL CORPput$0-2,050,200
-100.0%
-1.39%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2015-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPIRIT AEROSYSTEMS HLDGS INC39Q4 202228.3%
SPDR S&P 500 ETF TR31Q3 202316.9%
ISHARES TR28Q3 202310.9%
MANNKIND CORP24Q3 20230.5%
BAIDU INC21Q2 20188.6%
ITRON INC21Q3 202012.1%
RETROPHIN INC20Q3 20204.5%
HARMONIC INC19Q3 202310.5%
JOHNSON CTLS INTL PLC17Q3 20209.6%
ACORDA THERAPEUTICS INC17Q3 20194.0%

View SCOPIA CAPITAL MANAGEMENT LP's complete holdings history.

Latest significant ownerships (13-D/G)
SCOPIA CAPITAL MANAGEMENT LP Q2 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
VERRA MOBILITY CorpOctober 28, 20226,710,0744.4%
Spirit AeroSystems Holdings, Inc.February 14, 20222,084,2122.0%
Retrophin, Inc.February 14, 20202,011,6974.7%
Horizon Therapeutics Public Ltd CoJanuary 10, 20202,527,4561.4%
ZOGENIX, INC.January 10, 2020919,4842.1%
ITRON, INC.January 07, 20201,808,0594.6%
ACORDA THERAPEUTICS INCSold outNovember 12, 201900.0%
LA JOLLA PHARMACEUTICAL COApril 10, 2019480,0001.8%
Prothena Corp plcMarch 11, 20191,883,8164.7%
GW PHARMACEUTICALS PLCFebruary 14, 20191,345,1984.6%

View SCOPIA CAPITAL MANAGEMENT LP's complete significant-ownership history.

Latest filings
TypeFiled
SC 13D2024-04-26
13F-HR2024-02-14
SC 13G2024-02-14
SC 13D/A2024-01-22
13F-HR/A2023-11-14
13F-HR2023-11-14
SC 13D2023-09-21
13F-HR2023-08-14
13F-HR2023-05-15
SC 13D/A2023-04-12

View SCOPIA CAPITAL MANAGEMENT LP's complete filings history.

Compare quarters

Export SCOPIA CAPITAL MANAGEMENT LP's holdings